High density lipoprotein - should we raise it?

Area of Science:

• Cardiovascular Research
• Lipid Metabolism
• Atherosclerosis

Background:

• Low high-density lipoprotein (HDL) cholesterol is linked to increased coronary artery disease risk.
• HDL possesses anti-atherogenic properties, including cholesterol efflux and anti-inflammatory effects.
• The efficacy of raising HDL to reduce cardiovascular risk is under investigation.

Purpose of the Study:

• To investigate whether raising HDL cholesterol levels can reduce cardiovascular risk.
• To explore the heterogeneity and dysfunction of HDL in patients with cardiovascular disease or diabetes.
• To determine if HDL cholesterol levels alone are sufficient indicators for HDL-targeted therapies.

Main Methods:

• Review of experimental studies on HDL's anti-atherogenic properties.
• Analysis of gene-targeted mouse models with modified HDL levels.
• Examination of clinical trial data on HDL-raising interventions.

Main Results:

• HDL's vascular effects are heterogeneous and can be impaired in disease states ('HDL dysfunction').
• Genetic modifications increasing HDL levels can have opposing effects on atherosclerosis.
• HDL cholesterol levels alone do not predict the therapeutic success of HDL-raising strategies.

Conclusions:

• HDL cholesterol levels remain a marker for cardiovascular risk.
• The effectiveness of HDL-raising therapies depends on the specific intervention and its impact on HDL function.
• Further clinical trials are necessary to identify beneficial HDL-raising strategies.